CD8A and infection: In this context, our data provide evidence that a PD-L1 checkpoint blockade at the CD8+ T cell expansion phase not only restored resistance to T. cruzi absence of IL-17RA signaling, but also boosted protective CD8+ T cell immunity during the natural infection.